The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 11, 2015

Filed:

Sep. 02, 2010
Applicants:

Jeffrey Bruce Smaill, Auckland, NZ;

Adam Vorn Patterson, Auckland, NL;

Guo-liang LU, Auckland, NZ;

Ho Huat Lee, Auckland, NZ;

Amir Ashoorzadeh, Auckland, NZ;

Robert Forbes Anderson, Auckland, NZ;

William Robert Wilson, Waiuku, NZ;

William Alexander Denny, Manukau, NZ;

Huai-ling Annie Hsu, Auckland, NZ;

Andrej Maroz, Auckland, NZ;

Stephen Michael Frazer Jamieson, Auckland, NZ;

Alexandra Marie Mowday, Auckland, NZ;

Kendall Marie Carlin, Auckland, NZ;

Inventors:

Jeffrey Bruce Smaill, Auckland, NZ;

Adam Vorn Patterson, Auckland, NL;

Guo-Liang Lu, Auckland, NZ;

Ho Huat Lee, Auckland, NZ;

Amir Ashoorzadeh, Auckland, NZ;

Robert Forbes Anderson, Auckland, NZ;

William Robert Wilson, Waiuku, NZ;

William Alexander Denny, Manukau, NZ;

Huai-Ling Annie Hsu, Auckland, NZ;

Andrej Maroz, Auckland, NZ;

Stephen Michael Frazer Jamieson, Auckland, NZ;

Alexandra Marie Mowday, Auckland, NZ;

Kendall Marie Carlin, Auckland, NZ;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61P 35/00 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); C07D 471/04 (2013.01);
Abstract

The invention provides kinase inhibitors of Formula I: Also provided are reductive prodrugs, comprising a kinase inhibitor as defined above and a reductive trigger linked directly or indirectly to a nitrogen of the kinase inhibitor. Further provided are pharmaceutical compositions, comprising the kinase inhibitors or the prodrugs, and the use of such compositions in therapy, in particular for treating cancer.


Find Patent Forward Citations

Loading…